These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9130662)

  • 1. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma.
    Wen YJ; Lim SH
    Eur J Immunol; 1997 Apr; 27(4):1043-7. PubMed ID: 9130662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
    Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
    Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different properties of T-cell epitopes within complementarity-determining regions 1 and 2 of idiotypic VH in B-lymphoma.
    Wen YJ; Lim SH
    Scand J Immunol; 1999 Sep; 50(3):296-301. PubMed ID: 10447939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major histocompatibility complex class I-restricted presentation of influenza virus nucleoprotein peptide by B lymphoma cells harboring an antibody gene antigenized with the virus peptide.
    Billetta R; Filaci G; Zanetti M
    Eur J Immunol; 1995 Mar; 25(3):776-83. PubMed ID: 7705408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
    Liu Y; Zhu P; Hu YM
    Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vivo immune responses to idiotypic VH complementarity-determining region 3 peptide vaccination in B-cell non-Hodgkin's lymphoma.
    Wen YJ; Lim SH
    Br J Haematol; 1998 Dec; 103(3):663-8. PubMed ID: 9858214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells.
    Gricks CS; Rawlings E; Foroni L; Madrigal JA; Amlot PL
    Cancer Res; 2001 Jul; 61(13):5145-52. PubMed ID: 11431353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
    Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
    J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
    Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity.
    Reidl LS; Friedman DF; Goldman J; Hardy RR; Jefferies LC; Silberstein LE
    J Immunol; 1991 Nov; 147(10):3623-31. PubMed ID: 1940361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Function analysis of the family-specific CTL induced by peptides derived from IgHV gene framework region of B-cell malignance].
    Guo XL; Zhu P; Liu Y; Liu J; Zhu X
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):453-7. PubMed ID: 16383233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferation of specific cytotoxic T lymphocytes induced by immunoglobulin heavy chain framework region-derived antigenic nonapeptides].
    Liu Y; Zhu P; Hu YM
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):97-102. PubMed ID: 14990121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells.
    King CA; Wills MR; Hamblin TJ; Stevenson FK
    Cell Immunol; 1993 Apr; 147(2):411-24. PubMed ID: 8095858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VH-related idiotopes detected by site-directed mutagenesis. A study induced by the failure to find CD4 anti-idiotypic antibodies mimicking the cellular receptor of HIV.
    Weissenhorn W; Chen YH; Riethmüller G; Rieber EP; Weiss EH
    J Immunol; 1992 Aug; 149(4):1237-41. PubMed ID: 1500715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vaccinia viruses expressing immunoglobulin variable regions efficiently and selectively protect mice against tumoral B-cell growth.
    BenAmmar-Ceccoli S; Humblot S; Crouzier R; Acres B; Kieny MP; Herlyn D; Pasquali JL; Martin T
    Cancer Gene Ther; 2001 Oct; 8(10):815-26. PubMed ID: 11687905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.
    Lauritzsen GF; Bogen B
    Cell Immunol; 1993 Apr; 148(1):177-88. PubMed ID: 8098665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.